The hunt for the first-ever approved treatment for MOG Antibody Disease continues with another phase 3 clinical trial involving satralizumab. satralizumab will
MOG Antibody Disease (MOGAD)
MOG Antibody Disease, also known as MOG-IgG-associated disease or MOGAD, is a rare autoimmune disorder that affects the central nervous system (CNS), which includes the brain and spinal cord.
In MOG Antibody Disease, the immune system produces antibodies against a protein called myelin oligodendrocyte glycoprotein (MOG), which is found in the protective covering of nerve fibers in the CNS.
Learn more about MOG Antibody Disease
Understand Your Condition
Become the best advocate for your health through learning.
Discover Potential Solutions
Explore ways to aid your recovery and improve your symptoms.
Improve Your Recovery
Make changes to better your life and reduce the restrictions of your condition.
Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease or MOG Antibody Disease (MOGAD) is a condition that causes inflammation to the optic nerve(s), brain,
A diagnosis of MOG Antibody Disease (MOGAD) can be overwhelming and trigger grief. Grief is a strong, often overwhelming emotion involving loss.
MOG Antibody Disease (MOGAD) relapses are one of a patient's biggest challenges. In this blog post, you will learn what a relapse
The first ever MOG Antibody Disease phase 3 clinical trial is now taking place. A new drug called Rozanolixizumab will be trialed
MOGAD support groups allow members to share experiences about their diagnosis, treatment, feelings, and other first-hand experiences. Healthcare providers treating patients with MOGAD
Last week we were featured in our first-ever MOG Antibody Disease research article! The results of the Ignition Survey #2 Fatigue in
In collaboration with The MOG Project, MyMyelitis created the Ignition Survey 2 to explore fatigue in MOG Antibody Disease (MOGAD) within the community. Below
Important InformationPlease be aware that this is an emerging area of research, and this could change in the future!I want to thank